Case 2: Treating BRCA-Mutated Ovarian Cancer

Clinical Investigators Provide Perspectives on Cases of Patients with Ovarian and Endometrial CancerПодробнее

Case 2: Maintenance in BRCA1/2wt, HR-Proficient Ovarian CancerПодробнее

Cancer Topics - Contrasting Cases: Systemic Therapy for Metastatic Triple-negative Breast CancerПодробнее

Apollo Hospitals | Ovarian Cancer | Dr. Kumar GubbalaПодробнее

3/26/2021: Upfront Treatment of Advanced Ovarian Cancer; Ay, Now the Plot ThickensПодробнее

Case 2: Olaparib in BRCA-Mutated Ovarian CancerПодробнее

2021 Evolution Kansas City | Case 2: PreVivor (Gene Carrier Identified via Cascade Testing)Подробнее

Case 3: Recurrent Ovarian Cancer, Platinum-Sensitive, BRCA WTПодробнее

Interactive Webinar: What Women Need to Know about Ovarian CancerПодробнее

Case 2: Primary Treatment OptionsПодробнее

Case 2: Newly Diagnosed Ovarian Cancer, gBRCA-MutatedПодробнее

Ex vivo retrieval and cryopreservation of oocytes for FP in a BRCA1 mutation carrier...Подробнее

Breast Cancer: Concepts & Direction in 2010 | Memorial Sloan KetteringПодробнее

BRCA variant classification 2018 (Run 2) Q & AПодробнее

Breast Cancer Genes, Risk Assessment and Screening - Lawrence BrodyПодробнее